StonvexLoading…
StonvexStonvexStonvexCore line items from GILD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $29.44B | $28.75B | $27.12B | $27.28B |
Operating Income | $10.02B | $1.66B | $7.61B | $7.33B |
Net Income | $8.51B | $480.00M | $5.67B | $4.59B |
EPS (Diluted) | $6.78 | $0.38 | $4.50 | $3.64 |
Total Assets | $59.02B | $58.99B | $62.13B | $63.17B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $7.56B | $9.99B | $6.08B | $5.41B |
Free Cash Flow OCF − CapEx | $9.46B | $10.30B | $7.42B | $8.34B |
Shares Outstanding | 1.24B | 1.25B | 1.25B | 1.25B |